Geode Capital Management
FBLG icon

Geode Capital Management’s FibroBiologics FBLG Stock Holding History

Geode Capital Management’s Portfolio FBLG Stock Details FBLG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$39.2K Sell
30,169
-130
-0.4% -$152 ﹤0.01% 4245
2026
Q2 		$28.7K Buy
30,299
+690
+2% +$801 ﹤0.01% 4336
2026
Q1 		$39.1K Buy
29,609
+12,171
+70% +$72.4K ﹤0.01% 4366
2025
Q4 		$78.5K Buy
17,438
+2,991
+21% +$21.1K ﹤0.01% 4152
2025
Q3 		$158K Hold
14,447
– – ﹤0.01% 3999
2025
Q2 		$180K Sell
14,447
-16,285
-53% -$294K ﹤0.01% 3907
2025
Q1 		$553K Buy
30,732
+486
+2% +$13.9K ﹤0.01% 3503
2024
Q4 		$1.21M Buy
30,246
+258
+0.9% +$13.8K ﹤0.01% 3297
2024
Q3 		$1.85M Buy
29,988
+14,202
+90% +$944K ﹤0.01% 3152
2024
Q2 		$1.58M Buy
15,786
+15,237
+2,775% +$2.91M ﹤0.01% 3176
2024
Q1 		$119K Buy
+549
New +$132K ﹤0.01% 4109

Other funds holding FBLG

IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $83.6B AUM 19.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Grove Bank & Trust
Grove Bank & Trust Miami, Florida $1.01B AUM 19.76% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Allworth Financial
Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Geode Capital Management's FBLG Position: Q3 2026 in Review

Geode Capital Management reduced its FibroBiologics (FBLG) stake by 0.43% in Q3 2026, selling an estimated $152 and leaving 30,169 shares worth $39.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4245.

Geode Capital Management first reported a position in FBLG in Q1 2024 and has held it in 11 quarters since. The position peaked at $1.85M in Q3 2024. 9 funds tracked by Wall St. Rank hold FBLG as of Q3 2026.

  • Geode Capital Management held 30,169 shares of FibroBiologics worth $39.2K as of Q3 2026.
  • Geode Capital Management sold 130 FibroBiologics shares in Q3 2026, an estimated $152.
  • FibroBiologics made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #4245 holding.
  • Geode Capital Management first reported a position in FibroBiologics in Q1 2024 and has held it in 11 quarters since.
  • Geode Capital Management's FibroBiologics position peaked at $1.85M in Q3 2024.
  • 9 funds tracked by Wall St. Rank held FibroBiologics as of Q3 2026.

Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.